397 related articles for article (PubMed ID: 17126499)
21. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
Afonso MM; Pinchbeck GL; Smith SL; Daly JM; Gaskell RM; Dawson S; Radford AD
Vaccine; 2017 May; 35(20):2753-2760. PubMed ID: 28389099
[TBL] [Abstract][Full Text] [Related]
22. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
[TBL] [Abstract][Full Text] [Related]
23. Cross-reactivity among sapovirus recombinant capsid proteins.
Hansman GS; Natori K; Oka T; Ogawa S; Tanaka K; Nagata N; Ushijima H; Takeda N; Katayama K
Arch Virol; 2005 Jan; 150(1):21-36. PubMed ID: 15449145
[TBL] [Abstract][Full Text] [Related]
24. Virulent systemic feline calicivirus infection: local cytokine modulation and contribution of viral mutants.
Foley J; Hurley K; Pesavento PA; Poland A; Pedersen NC
J Feline Med Surg; 2006 Feb; 8(1):55-61. PubMed ID: 16213763
[TBL] [Abstract][Full Text] [Related]
25. Genetic and phylogenetic analyses of capsid protein gene in feline calicivirus isolates from Rio Grande do Sul in southern Brazil.
Henzel A; Sá e Silva M; Luo S; Lovato LT; Weiblen R
Virus Res; 2012 Feb; 163(2):667-71. PubMed ID: 22197423
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the N-terminal polypeptide of the capsid precursor protein and the ORF3 product of feline calicivirus.
Tohya Y; Shinchi H; Matsuura Y; Maeda K; Ishiguro S; Mochizuki M; Sugimura T
J Vet Med Sci; 1999 Sep; 61(9):1043-7. PubMed ID: 10535511
[TBL] [Abstract][Full Text] [Related]
27. Tissue distribution of virus replication in cats experimentally infected with distinct feline calicivirus isolates.
Truyen U; Geissler K; Hirschberger J
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):355-8. PubMed ID: 10507186
[TBL] [Abstract][Full Text] [Related]
28. Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats.
Wensman JJ; Samman A; Lindhe A; Thibault JC; Berndtsson LT; Hosie MJ
Acta Vet Scand; 2015 Dec; 57():86. PubMed ID: 26655039
[TBL] [Abstract][Full Text] [Related]
29. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
[TBL] [Abstract][Full Text] [Related]
30. An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus.
Pedersen NC; Elliott JB; Glasgow A; Poland A; Keel K
Vet Microbiol; 2000 May; 73(4):281-300. PubMed ID: 10781727
[TBL] [Abstract][Full Text] [Related]
31. [Yearly booster vaccine against feline calicivirus (FCV) for high risk cases].
Tijdschr Diergeneeskd; 2007 May; 132(10):402. PubMed ID: 17578234
[No Abstract] [Full Text] [Related]
32. Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats.
Sato H; Sehata G; Okada N; Iwamoto K; Masubuchi K; Kainuma R; Noda T; Igarashi T; Sawada T; Noro T; Oishi E
J Gen Virol; 2017 Jul; 98(7):1730-1738. PubMed ID: 28691897
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
Scott FW
Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
[TBL] [Abstract][Full Text] [Related]
34. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
Lappin MR; Andrews J; Simpson D; Jensen WA
J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445
[TBL] [Abstract][Full Text] [Related]
35. A severe dual infection by feline panleukopenia virus and feline calicivirus in an adult cat.
Camero M; Cavalli A; Bozzo G; Decaro N; Aliberti A; Martella V; Pratelli A; Buonavoglia C
New Microbiol; 2004 Jan; 27(1):79-82. PubMed ID: 14964410
[TBL] [Abstract][Full Text] [Related]
36. Questions long-term immunity in cats.
Norsworthy GD
J Am Vet Med Assoc; 1999 Aug; 215(3):316-7. PubMed ID: 10434959
[No Abstract] [Full Text] [Related]
37. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
38. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo.
Poulet H; Jas D; Lemeter C; Coupier C; Brunet S
Vaccine; 2008 Jul; 26(29-30):3647-54. PubMed ID: 18541348
[TBL] [Abstract][Full Text] [Related]
40. Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.
Spiri AM; Riond B; Stirn M; Novacco M; Meli ML; Boretti FS; Herbert I; Hosie MJ; Hofmann-Lehmann R
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
